Design Therapeutics

+$1.47 (+5.53%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DSGN and other stocks, options, and ETFs commission-free!

About DSGN

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.

CEO
Joao Siffert
Employees
15
Headquarters
Carlsbad, California
Founded
2017

DSGN Key Statistics

Market Cap
1.59B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
101.77K
High Today
$28.10
Low Today
$26.62
Open Price
$26.62
Volume
40.82K
52 Week High
$50.50
52 Week Low
$18.81

DSGN Earnings

Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market

You May Also Like

GTPA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure